Cost–effectiveness of statins revisited: lessons learned about the value of innovation
Year of publication: |
2012
|
---|---|
Authors: | Lindgren, Peter ; Jönsson, Bengt |
Published in: |
The European Journal of Health Economics. - Springer. - Vol. 13.2012, 4, p. 445-450
|
Publisher: |
Springer |
Subject: | Simvastatin | Consumer surplus | Producer surplus | Cardiovascular disease |
-
Optimal information disclosure and market outcomes
Hopenhayn, Hugo Andrés, (2023)
-
Phan Sy Hieu, (2015)
-
On the treatment of foreigners and foreign-owned firms in cost–benefit analysis
Johansson, Per-Olov, (2015)
- More ...
-
Costs and quality of life in multiple sclerosis: A cross-sectional observational study in Germany
Kobelt, Gisela, (2000)
-
Costs and quality of life in multiple sclerosis: A cross-sectional observational study in the UK
Kobelt, Gisela, (2000)
-
Zethraeus, Niklas, (2000)
- More ...